Literature DB >> 26634744

The roles of microRNAs in Wilms' tumors.

Xin Yu1, Zheng Li2, Matthew T V Chan3, William Ka Kei Wu3,4.   

Abstract

Wilms' tumor is the most common renal tumor in children in which diffusely anaplastic or unfavorable histology foreshadows poor prognosis. MicroRNAs are small, non-coding RNAs that negatively regulate gene expression at the posttranscriptional level. Accumulating evidence shows that microRNA dysregulation takes part in the pathogenesis of many renal diseases, such as chronic kidney diseases, polycystic kidney disease, renal fibrosis, and renal cancers. In Wilms' tumor, dysregulation of some key oncogenic or tumor-suppressing microRNAs, such as miR-17~92 cluster, miR-185, miR-204, and miR-483, has been documented. In this review, we will summarize current evidence on the role of dysregulated microRNAs in the development of Wilms' tumor.

Entities:  

Keywords:  MicroRNAs; Nephroblastoma; Wilms’ tumor

Mesh:

Substances:

Year:  2015        PMID: 26634744     DOI: 10.1007/s13277-015-4514-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  75 in total

1.  The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells.

Authors:  Stephen J Libertini; Honglin Chen; Bushra al-Bataina; Tilak Koilvaram; Michael George; Allen C Gao; Maria Mudryj
Journal:  Prostate       Date:  2011-08-11       Impact factor: 4.104

2.  Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.

Authors:  Bertrand Isidor; Franck Bourdeaut; Delfine Lafon; Ghislaine Plessis; Elodie Lacaze; Caroline Kannengiesser; Sylvie Rossignol; Olivier Pichon; Annaig Briand; Dominique Martin-Coignard; Maria Piccione; Albert David; Olivier Delattre; Cécile Jeanpierre; Nicolas Sévenet; Cédric Le Caignec
Journal:  Eur J Hum Genet       Date:  2012-11-21       Impact factor: 4.246

3.  miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.

Authors:  Hailin Tang; Peng Liu; Lu Yang; Xinhua Xie; Feng Ye; Minqing Wu; Xiaoping Liu; Bo Chen; Lijuan Zhang; Xiaoming Xie
Journal:  Mol Cancer Ther       Date:  2014-10-15       Impact factor: 6.261

4.  miR-99a directly targets the mTOR signalling pathway in breast cancer side population cells.

Authors:  Z Yang; Y Han; K Cheng; G Zhang; X Wang
Journal:  Cell Prolif       Date:  2014-10-27       Impact factor: 6.831

5.  Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney.

Authors:  Benjamin Dekel; Sally Metsuyanim; Kai M Schmidt-Ott; Edi Fridman; Jasmin Jacob-Hirsch; Amos Simon; Jehonathan Pinthus; Yoram Mor; Jonathan Barasch; Ninette Amariglio; Yair Reisner; Naftali Kaminski; Gideon Rechavi
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

6.  Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.

Authors:  Takeshi Aoba; Naoto Urushihara; Koji Fukumoto; Shigeyuki Furuta; Hiroaki Fukuzawa; Maki Mitsunaga; Kentaro Watanabe; Masaya Yamoto; Hiromu Miyake; Mariko Koyama; Hideto Iwabuchi; Junki Koike; Shinobu Tatsunami; Munechika Wakisaka; Hiroaki Kitagawa
Journal:  J Pediatr Surg       Date:  2012-12       Impact factor: 2.545

7.  Incidence and outcomes of patients with late recurrence of Wilms' tumor.

Authors:  M Malogolowkin; F Spreafico; J S Dome; H van Tinteren; K Pritchard-Jones; M M van den Heuvel-Eibrink; C Bergeron; J de Kraker; N Graf
Journal:  Pediatr Blood Cancer       Date:  2013-06-04       Impact factor: 3.167

Review 8.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

Review 9.  The role of microRNAs expression in laryngeal cancer.

Authors:  Xin Yu; Zheng Li
Journal:  Oncotarget       Date:  2015-09-15

10.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.

Authors:  Young-Kook Kim; Jieun Yu; Tae Su Han; Seong-Yeon Park; Bumjin Namkoong; Dong Hyuk Kim; Keun Hur; Moon-Won Yoo; Hyuk-Joon Lee; Han-Kwang Yang; V Narry Kim
Journal:  Nucleic Acids Res       Date:  2009-01-19       Impact factor: 16.971

View more
  9 in total

1.  MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms' Tumor Cell by Targeting PBOV1.

Authors:  Zheng-Tuan Guo; Qiang Yu; Chunlin Miao; Wenan Ge; Peng Li
Journal:  Mol Cell Biol       Date:  2022-07-11       Impact factor: 5.069

Review 2.  Recent advances in the management of Wilms' tumor.

Authors:  Roberto I Lopes; Armando Lorenzo
Journal:  F1000Res       Date:  2017-05-12

3.  MiR-1180-5p regulates apoptosis of Wilms' tumor by targeting p73.

Authors:  Xiuyun Jiang; Huaicheng Li
Journal:  Onco Targets Ther       Date:  2018-02-16       Impact factor: 4.147

4.  Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.

Authors:  Feng Zhang; Liping Zeng; Qinming Cai; Zihao Xu; Ruida Liu; Haicheng Zhong; Robert Mukiibi; Libin Deng; Xiaoli Tang; Hongbo Xin
Journal:  Cancer Control       Date:  2020 Apr-Jun       Impact factor: 3.302

5.  Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor.

Authors:  Zifeng Liu; Wenbo Zhao; Yuqing Ren; Chang Liu; Xun Liu; Jian Xiao
Journal:  Oncol Lett       Date:  2020-03-31       Impact factor: 2.967

6.  MicroRNA‑92a‑3p inhibits the cell proliferation, migration and invasion of Wilms tumor by targeting NOTCH1.

Authors:  Shibo Zhu; Liyu Zhang; Zhang Zhao; Wen Fu; Kai Fu; Guochang Liu; Wei Jia
Journal:  Oncol Rep       Date:  2018-05-23       Impact factor: 3.906

Review 7.  Role of miR-483 in digestive tract cancers: from basic research to clinical value.

Authors:  Wei Zhou; Wanli Yang; Jiaojiao Ma; Hongwei Zhang; Zeng Li; Lei Zhang; Jinqiang Liu; Zhenyu Han; Hu Wang; Liu Hong
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

8.  Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.

Authors:  Hong Zheng; Bai-Hui Li; Chang Liu; Li Jia; Feng-Ting Liu
Journal:  Biomed Res Int       Date:  2020-02-21       Impact factor: 3.411

Review 9.  Research advances in the targeted therapy and immunotherapy of Wilms tumor: a narrative review.

Authors:  Bo Hong; Rui Dong
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.